CRISPR Therapeutics AG Peer Comparison
Metric | Value | Ranking | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $3.7 Billion | 5/15 | NVO $367.3B |
REGN $71.5B |
SRPT $10.5B |
KRYS $4.4B |
CRSP $3.7B |
BEAM $2.4B |
NTLA $968.6M |
VERV $661.2M |
FATE $142.4M |
CRBU $116.8M |
EDIT $98.2M |
RAIN $26.1M |
AVRO $5.2M |
HEPA $2.1M |
CWBR $1.2M |
Gross Margin | -100% | 14/15 | NTLA 100% |
FATE 100% |
CRBU 100% |
REGN 93% |
KRYS 90% |
NVO 84% |
SRPT 80% |
VERV 74% |
BEAM 62% |
CWBR 0% |
AVRO 0% |
HEPA 0% |
RAIN 0% |
CRSP -100% |
EDIT -100% |
Profit Margin | -100% | 9/15 | NVO 38% |
KRYS 32% |
REGN 24% |
SRPT 7% |
CWBR 0% |
AVRO 0% |
HEPA 0% |
RAIN 0% |
CRSP -100% |
EDIT -100% |
NTLA -100% |
FATE -100% |
BEAM -100% |
CRBU -100% |
VERV -100% |
EBITDA margin | -18294% | 14/15 | NVO 52% |
KRYS 27% |
REGN 26% |
SRPT 5% |
CWBR -100% |
AVRO -100% |
HEPA -100% |
RAIN -100% |
BEAM -639% |
VERV -829% |
NTLA -1490% |
FATE -1704% |
CRBU -1889% |
CRSP -18294% |
EDIT -101870% |
Quarterly Revenue | $602,000 | 10/15 | NVO $10.5B |
REGN $3.8B |
SRPT $467.2M |
KRYS $83.8M |
BEAM $14.3M |
NTLA $9.1M |
VERV $6.9M |
FATE $3.1M |
CRBU $2.0M |
CRSP $602,000 |
EDIT $61,000 |
CWBR $0 |
AVRO $0 |
HEPA $0 |
RAIN $0 |
Quarterly Earnings | -$85.9 Million | 13/15 | NVO $4.0B |
REGN $917.7M |
SRPT $33.6M |
KRYS $27.2M |
RAIN -$3.0M |
CWBR -$4.3M |
HEPA -$4.9M |
AVRO -$6.8M |
CRBU -$34.7M |
FATE -$47.7M |
VERV -$50.1M |
EDIT -$62.1M |
CRSP -$85.9M |
BEAM -$96.7M |
NTLA -$135.7M |
Quarterly Free Cash Flow | -$107.1 Million | 13/15 | NVO $4.6B |
KRYS $57.8M |
CWBR -$1.8M |
HEPA -$2.5M |
AVRO -$7.6M |
FATE -$29.9M |
CRBU -$33.3M |
VERV -$40.5M |
EDIT -$55.5M |
NTLA -$86.1M |
BEAM -$89.7M |
SRPT -$98.0M |
CRSP -$107.1M |
REGN -$0 |
RAIN -$0 |
Trailing 4 Quarters Revenue | $201.6 Million | 6/15 | NVO $39.9B |
REGN $14.2B |
SRPT $1.6B |
BEAM $349.6M |
KRYS $241.5M |
CRSP $201.6M |
EDIT $61.8M |
NTLA $43.1M |
VERV $24.4M |
FATE $13.4M |
CRBU $11.5M |
CWBR $0 |
AVRO $0 |
HEPA $0 |
RAIN $0 |
Trailing 4 Quarters Earnings | -$239.6 Million | 14/15 | NVO $10.5B |
REGN $3.8B |
SRPT $467.2M |
KRYS $83.8M |
BEAM $14.3M |
NTLA $9.1M |
VERV $6.9M |
FATE $3.1M |
CRBU $2.0M |
CRSP $602,000 |
EDIT $61,000 |
CWBR -$0 |
AVRO -$0 |
HEPA -$0 |
RAIN -$0 |
Quarterly Earnings Growth | 23% | 6/15 | SRPT 182% |
KRYS 182% |
RAIN 84% |
AVRO 72% |
HEPA 54% |
CRSP 23% |
NVO 21% |
BEAM -1% |
FATE -6% |
VERV -10% |
NTLA -11% |
REGN -21% |
EDIT -38% |
CWBR -59% |
CRBU -247% |
Annual Earnings Growth | 31% | 6/15 | SRPT 208% |
KRYS 133% |
RAIN 63% |
BEAM 58% |
HEPA 57% |
CRSP 31% |
NVO 17% |
FATE 8% |
REGN 5% |
VERV 5% |
CWBR 1% |
NTLA -6% |
EDIT -27% |
CRBU -50% |
AVRO -59% |
Quarterly Revenue Growth | 0% | 6/15 | VERV 120% |
FATE 58% |
SRPT 41% |
NVO 21% |
REGN 10% |
CRSP 0% |
EDIT 0% |
KRYS 0% |
CWBR 0% |
AVRO 0% |
HEPA 0% |
RAIN 0% |
BEAM -17% |
NTLA -24% |
CRBU -91% |
Annual Revenue Growth | -4% | 13/15 | EDIT 613% |
BEAM 351% |
FATE 184% |
VERV 160% |
SRPT 47% |
NVO 22% |
REGN 5% |
KRYS 0% |
CWBR 0% |
AVRO 0% |
HEPA 0% |
RAIN 0% |
CRSP -4% |
NTLA -18% |
CRBU -67% |
Cash On Hand | $225.7 Million | 4/15 | NVO $8.4B |
KRYS $374.0M |
BEAM $230.2M |
CRSP $225.7M |
SRPT $197.9M |
VERV $158.7M |
NTLA $120.5M |
EDIT $95.8M |
AVRO $90.8M |
FATE $37.9M |
CRBU $32.0M |
CWBR $6.2M |
HEPA $1.5M |
RAIN $239,857 |
REGN -$0 |
Short Term Debt | $16.9 Million | 4/15 | NVO $814.2M |
SRPT $91.6M |
NTLA $19.2M |
CRSP $16.9M |
EDIT $16.4M |
BEAM $12.9M |
VERV $10.4M |
FATE $6.9M |
HEPA $2.2M |
KRYS $1.3M |
CRBU $1.2M |
RAIN $806,929 |
AVRO $224,000 |
REGN -$0 |
CWBR -$0 |
Long Term Debt | $210.7 Million | 5/15 | NVO $7.6B |
REGN $2.0B |
SRPT $1.3B |
BEAM $298.3M |
CRSP $210.7M |
FATE $92.1M |
NTLA $82.4M |
VERV $60.9M |
CRBU $25.5M |
EDIT $22.1M |
KRYS $0 |
CWBR $0 |
AVRO $0 |
HEPA $0 |
RAIN $0 |
PE | -1.00 | 6/15 | SRPT 86.01 |
KRYS 83.10 |
NVO 26.29 |
REGN 16.21 |
AVRO 0.17 |
CRSP -1.00 |
EDIT -1.00 |
NTLA -1.00 |
FATE -1.00 |
CWBR -1.00 |
HEPA -1.00 |
BEAM -1.00 |
RAIN -1.00 |
CRBU -1.00 |
VERV -1.00 |
PS | 18.33 | 4/15 | NVO 62.40 |
VERV 27.10 |
NTLA 22.48 |
CRSP 18.33 |
KRYS 18.02 |
FATE 10.59 |
CRBU 10.18 |
BEAM 6.77 |
SRPT 6.39 |
REGN 5.04 |
EDIT 1.59 |
CWBR -1.00 |
AVRO -1.00 |
HEPA -1.00 |
RAIN -1.00 |
PB | 1.91 | 6/15 | NVO 20.66 |
SRPT 8.58 |
KRYS 4.91 |
BEAM 2.99 |
REGN 2.05 |
CRSP 1.91 |
VERV 1.30 |
NTLA 1.01 |
EDIT 0.56 |
CRBU 0.42 |
FATE 0.39 |
CWBR 0.13 |
AVRO 0.06 |
HEPA 0.00 |
RAIN 0.00 |
PC | 16.38 | 4/15 | RAIN 108.73 |
SRPT 52.97 |
NVO 43.68 |
CRSP 16.38 |
KRYS 11.64 |
BEAM 10.28 |
NTLA 8.04 |
VERV 4.17 |
FATE 3.76 |
CRBU 3.65 |
HEPA 1.42 |
EDIT 1.03 |
CWBR 0.19 |
AVRO 0.06 |
REGN -1.00 |
Liabilities to Equity | 0.16 | 10/15 | NVO 2.30 |
SRPT 1.95 |
EDIT 0.87 |
BEAM 0.48 |
FATE 0.37 |
CWBR 0.32 |
VERV 0.31 |
NTLA 0.22 |
CRBU 0.22 |
CRSP 0.16 |
KRYS 0.11 |
REGN 0.08 |
AVRO 0.04 |
HEPA 0.00 |
RAIN 0.00 |
ROA | -0.11 | 6/15 | AVRO 33% | REGN 12% | KRYS 5% | NVO 4% | SRPT 3% | CRSP -11% | BEAM -12% | VERV -30% | FATE -38% | CRBU -43% | NTLA -45% | EDIT -64% | CWBR -99% | HEPA -611% | RAIN -4232% |
ROE | -0.12 | 8/15 | HEPA 5583% |
RAIN 3979% |
AVRO 34% |
REGN 13% |
NVO 12% |
SRPT 10% |
KRYS 6% |
CRSP -12% |
BEAM -18% |
VERV -39% |
FATE -52% |
CRBU -53% |
NTLA -54% |
EDIT -120% |
CWBR -131% |
Current Ratio | 7.13 | 4/15 | AVRO 26.32 |
REGN 13.50 |
KRYS 10.18 |
CRSP 7.13 |
NTLA 5.57 |
CRBU 5.45 |
VERV 4.27 |
CWBR 4.17 |
FATE 3.73 |
BEAM 3.08 |
EDIT 2.16 |
SRPT 1.51 |
NVO 1.44 |
HEPA 0.90 |
RAIN 0.48 |
Quick Ratio | 6.12 | 3/15 | SRPT 86.01 |
KRYS 83.10 |
NVO 26.29 |
REGN 16.21 |
AVRO 0.17 |
CRSP -1.00 |
EDIT -1.00 |
NTLA -1.00 |
FATE -1.00 |
CWBR -1.00 |
HEPA -1.00 |
BEAM -1.00 |
RAIN -1.00 |
CRBU -1.00 |
VERV -1.00 |
Long Term Debt to Equity | 0.11 | 7/15 | SRPT} 1.07 |
NVO} 0.43 |
BEAM} 0.38 |
FATE} 0.25 |
EDIT} 0.13 |
VERV} 0.12 |
CRSP} 0.11 |
NTLA} 0.09 |
CRBU} 0.09 |
REGN} 0.06 |
KRYS} 0.00 |
CWBR} 0.00 |
AVRO} 0.00 |
HEPA} 0.00 |
RAIN} 0.00 |
Debt to Equity | 0.12 | 7/15 | SRPT 1.14 |
NVO 0.47 |
FATE 0.27 |
EDIT 0.22 |
BEAM 0.20 |
VERV 0.14 |
CRSP 0.12 |
NTLA 0.11 |
CRBU 0.09 |
REGN 0.06 |
KRYS 0.00 |
CWBR 0.00 |
AVRO 0.00 |
RAIN -1.00 |
HEPA -5.47 |
Burn Rate | 2.29 | 4/15 | AVRO 13.22 |
SRPT 4.76 |
VERV 2.88 |
CRSP 2.29 |
BEAM 2.06 |
EDIT 1.43 |
CWBR 1.43 |
CRBU 0.89 |
NTLA 0.84 |
FATE 0.71 |
HEPA 0.28 |
RAIN 0.07 |
REGN 0.00 |
KRYS -13.92 |
NVO -96.87 |
Cash to Cap | 0.06 | 11/15 | AVRO 17.33 |
CWBR 5.20 |
EDIT 0.98 |
HEPA 0.70 |
FATE 0.27 |
CRBU 0.27 |
VERV 0.24 |
NTLA 0.12 |
BEAM 0.10 |
KRYS 0.09 |
CRSP 0.06 |
NVO 0.02 |
SRPT 0.02 |
RAIN 0.01 |
REGN 0.00 |
CCR | 1.25 | 2/15 | KRYS 2.13 |
CRSP 1.25 |
NVO 1.15 |
AVRO 1.11 |
CRBU 0.96 |
BEAM 0.93 |
EDIT 0.89 |
VERV 0.81 |
NTLA 0.63 |
FATE 0.63 |
HEPA 0.52 |
CWBR 0.42 |
SRPT -2.91 |
REGN |
RAIN |
EV to EBITDA | -33.58 | 15/15 | SRPT} 526.23 |
KRYS} 177.39 |
REGN} 74.25 |
NVO} 1.45 |
EDIT} -0.66 |
CWBR} -1.00 |
AVRO} -1.00 |
HEPA} -1.00 |
RAIN} -1.00 |
CRBU} -2.92 |
FATE} -3.88 |
NTLA} -7.00 |
VERV} -10.08 |
BEAM} -25.20 |
CRSP} -33.58 |
EV to Revenue | 18.34 | 3/15 | VERV 23.52 |
NTLA 22.04 |
CRSP 18.34 |
KRYS 16.48 |
FATE 15.13 |
CRBU 9.72 |
SRPT 7.12 |
BEAM 6.57 |
REGN 5.18 |
NVO 1.36 |
EDIT 0.66 |
CWBR -1.00 |
AVRO -1.00 |
HEPA -1.00 |
RAIN -1.00 |